- Home
- CODX vs CVKD Comparison
CODX vs CVKD Comparison
Compare CODX & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- CVKD
- Stock Information
- Founded
- CODX 2013
- CVKD 2022
- Country
- CODX United States
- CVKD United States
- Employees
- CODX N/A
- CVKD N/A
- Industry
- CODX Medical/Dental Instruments
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- CODX Health Care
- CVKD Health Care
- Exchange
- CODX Nasdaq
- CVKD Nasdaq
- Market Cap
- CODX 22.0M
- CVKD 34.2M
- IPO Year
- CODX 2017
- CVKD 2023
- Fundamental
- Price
- CODX $0.48
- CVKD $17.45
- Analyst Decision
- CODX Hold
- CVKD Strong Buy
- Analyst Count
- CODX 1
- CVKD 1
- Target Price
- CODX $1.50
- CVKD $32.00
- AVG Volume (30 Days)
- CODX 199.5K
- CVKD 45.7K
- Earning Date
- CODX 05-08-2025
- CVKD 05-08-2025
- Dividend Yield
- CODX N/A
- CVKD N/A
- EPS Growth
- CODX N/A
- CVKD N/A
- EPS
- CODX N/A
- CVKD N/A
- Revenue
- CODX $7,321,012.00
- CVKD N/A
- Revenue This Year
- CODX N/A
- CVKD N/A
- Revenue Next Year
- CODX N/A
- CVKD N/A
- P/E Ratio
- CODX N/A
- CVKD N/A
- Revenue Growth
- CODX 57.16
- CVKD N/A
- 52 Week Low
- CODX $0.46
- CVKD $5.40
- 52 Week High
- CODX $2.23
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- CODX 31.25
- CVKD 47.10
- Support Level
- CODX $0.46
- CVKD $14.64
- Resistance Level
- CODX $0.68
- CVKD $19.93
- Average True Range (ATR)
- CODX 0.07
- CVKD 2.05
- MACD
- CODX 0.00
- CVKD -0.22
- Stochastic Oscillator
- CODX 12.00
- CVKD 34.02
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.